Evidence map›Paper›PMID 28341391›Full record

ArticleJournal of hepatology2017

Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.

Morgan E Preziosi, Sucha Singh, Erika V Valore, Grace Jung, Branimir Popovic, Minakshi Poddar, Shanmugam Nagarajan, Tomas Ganz, Satdarshan P Monga

Open access · greenAbstract read
In one paragraph

Article in Journal of hepatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Iron Dysregulation in Cardiovascular Diseases.Reviews in cardiovascular medicine · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Iron as a therapeutic target in chronic liver disease.World journal of gastroenterology · 2023
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Food science & nutrition · 2021
    Article
  16. Review
  17. Article
  18. Article
  19. Generic chemoprevention of hepatocellular carcinoma.Annals of the New York Academy of Sciences · 2019
    Review
  20. Iron and liver fibrosis: Mechanistic and clinical aspects.World journal of gastroenterology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Morgan E PreziosiDepartment of Pathology (Division of Experimental Pathology), University of Pittsburgh, Pennsylvania, United States; Pittsburgh Liver Research Center, University of Pittsburgh, Pennsylvania, United States.
Sucha SinghDepartment of Pathology (Division of Experimental Pathology), University of Pittsburgh, Pennsylvania, United States; Pittsburgh Liver Research Center, University of Pittsburgh, Pennsylvania, United States.
Erika V ValoreDepartment of Medicine University of California at Los Angeles, Los Angeles, CA, United States; Department of Pathology and Laboratory Medicine, University of California at Los Angeles, Los Angeles, CA, United States.
Grace JungDepartment of Medicine University of California at Los Angeles, Los Angeles, CA, United States; Department of Pathology and Laboratory Medicine, University of California at Los Angeles, Los Angeles, CA, United States.
Branimir PopovicDepartment of Pathology (Division of Experimental Pathology), University of Pittsburgh, Pennsylvania, United States.
Minakshi PoddarDepartment of Pathology (Division of Experimental Pathology), University of Pittsburgh, Pennsylvania, United States; Pittsburgh Liver Research Center, University of Pittsburgh, Pennsylvania, United States.
Shanmugam NagarajanDepartment of Pathology (Division of Experimental Pathology), University of Pittsburgh, Pennsylvania, United States; Pittsburgh Liver Research Center, University of Pittsburgh, Pennsylvania, United States.
Tomas GanzDepartment of Medicine University of California at Los Angeles, Los Angeles, CA, United States; Department of Pathology and Laboratory Medicine, University of California at Los Angeles, Los Angeles, CA, United States.
Satdarshan P MongaDepartment of Pathology (Division of Experimental Pathology), University of Pittsburgh, Pennsylvania, United States; Pittsburgh Liver Research Center, University of Pittsburgh, Pennsylvania, United States; Department of Medicine (Division of Gastroenterology, Hepatology and Nutrition), University of Pittsburgh, Pennsylvania, United States. Electronic address: smonga@pitt.edu.
University of Pittsburgh · USUniversity of California, Los Angeles · US

Funding

Role of Wnt/Beta-Catenin Signaling in Liver DevelopmentR01DK062277 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Satdarshan Singh Monga · 2004 to 2026
$9.0M
The Impact of Fc gamma Receptor Signaling on Lupus-Induced AtherosclerosisR01HL130126 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI NAGARAJAN, SHANMUGAM · 2016 to 2019
$1.5M
Targeting beta-catenin in liver pathology: Novel Interactions, Novel ParadigmsR01DK100287 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MONGA, SATDARSHAN SINGH · 2013 to 2016
$1.3M
NHLBI NIH HHS R01 HL130126NIDDK NIH HHS R01 DK062277NIDDK NIH HHS R01 DK100287
6 · The paper itself

Abstract

BACKGROUND &

aimsIron overload disorders such as hereditary hemochromatosis and iron loading anemias are a common cause of morbidity from liver diseases and increase risk of hepatic fibrosis and hepatocellular carcinoma (HCC). Treatment options for iron-induced damage are limited, partly because there is lack of animal models of human disease. Therefore, we investigated the effect of iron overload in liver-specific β-catenin knockout mice (KO), which are susceptible to injury, fibrosis and tumorigenesis following chemical carcinogen exposure.

methodsIron overload diet was administered to KO and littermate control (CON) mice for various times. To ameliorate an oxidant-mediated component of tissue injury, N-Acetyl-L-(+)-cysteine (NAC) was added to drinking water of mice on iron overload diet.

resultsKO on iron diet (KO +Fe) exhibited remarkable inflammation, followed by steatosis, oxidative stress, fibrosis, regenerating nodules and occurrence of occasional HCC. Increased injury in KO +Fe was associated with activated protein kinase B (AKT), ERK, and NF-κB, along with reappearance of β-catenin and target gene Cyp2e1, which promoted lipid peroxidation and hepatic damage. Addition of NAC to drinking water protected KO +Fe from hepatic steatosis, injury and fibrosis, and prevented activation of AKT, ERK, NF-κB and reappearance of β-catenin.

conclusionsThe absence of hepatic β-catenin predisposes mice to hepatic injury and fibrosis following iron overload, which was reminiscent of hemochromatosis and associated with enhanced steatohepatitis and fibrosis. Disease progression was notably alleviated by antioxidant therapy, which supports its chemopreventive role in the management of chronic iron overload disorders. LAY SUMMARY: Lack of animal models for iron overload disorders makes it hard to study the disease process for improving therapies. Feeding high iron diet to mice that lack the β-catenin gene in liver cells led to increased inflammation followed by fat accumulation, cell death and wound healing that mimicked human disease. Administration of an antioxidant prevented hepatic injury in this model.

Indexed as

AcetylcysteineAnimalsAntioxidantsbeta CateninDisease Models, AnimalFatty LiverFemaleHemochromatosisHumansIron OverloadLiverLiver CirrhosisMaleMiceMice, KnockoutOxidative StressAcetylcysteineAntioxidantsbeta CateninCTNNB1 protein, mouseCytochrome P-450 CYP2E1HemochromatosisKnockoutLipid peroxidationMiceNF-kappa BOxidative stressWnt signaling

Identifiers

PMID28341391
PMCPMC5515705
OpenAlexW2600017034

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.